Neratinib trials for HER2-positive Breast Cancer

All Neratinib trials · All HER2-positive Breast Cancer trials

Phase breakdown

Recruiting trials studying Neratinib for HER2-positive Breast Cancer

• Adjuvant Therapy With Neratinib in HER2 Positive Early Breast Cancer
  NCT06693024 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
  NCT01042379 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 42 locations
• Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers
  NCT04886531 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations

Common questions

How many trials study Neratinib for HER2-positive Breast Cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.